ABSTRACT 3-Methyladenine (5 mM) inhibits endogenous protein degradation in isolated rat hepatocytes by about 60%, while having no adverse effect on the degradation of an exogenous protein (asialofetuin), on protein synthesis, or on intracellular ATP levels. 3-Methyladenine appears to act specifically upon the autophagic/lysosomal pathway of degradation, as judged from its lack of effect in the presence of amino acids or a lysosomotropic amine (propylamine). The effect of the purine is not mediated by amino acids because the inhibition of protein degradation is accompanied by a significant depression of intracellular amino acid levels. The ability of 3-methyladenine to suppress the formation of electron microscopically visible autophagosomes suggests that it may be regarded as a specific inhibitor of autophagy.
Intracellular protein degradation takes place by both lysosomal and nonlysosomal mechanisms (1) (2) (3) . The lysosomes play a major role in (i) the degradation of exogenous proteins (4-7) and (ii) the degradation of endogenous proteins under conditions of amino acid starvation (step-down) (3, 8, 9) . Amino acids apparently exert their regulatory effect by suppressing the first step in the autophagic/lysosomal pathway-i.e., the formation of autophagosomes (10, 11) . Nothing is known, however, about the biochemical mechanisms involved in autophagy.
We have found that, like the amino acids, certain N6-methylated adenosine derivatives (6-dimethylaminopurine riboside and puromycin aminonucleoside) could specifically inhibit the degradation of endogenous protein by the autophagic/lysosomal pathway in isolated rat hepatocytes (12) . In a subsequent screening of a large number of purines and related substances (unpublished data), one compound-3-methyladenine-showed a unique selectivity in being able to inhibit endogenous protein degradation strongly without affecting protein synthesis. In the present report, the effects of 3-methyladenine are described in detail, and it is shown that this purine is capable of suppressing autophagosome formation independently of amino acids.
MATERIALS AND METHODS Chemicals. 3-Methyladenine (6-amino-3-methyl-purine) was purchased from Fluka, Buchs, Switzerland. 3-Methyladenosine (p-toluene sulfonate salt) was a gift from T. Fujii (Kanazawa University, Kanazawa, Japan). The other 3-substituted adenine derivatives (identified by their NSC code numbers) were donated by the Drug Synthesis and Chemistry Branch, Division of Cancer Treatment, National Cancer Institute (Bethesda, MD). Propylamine was purchased from Koch-Light Laboratories (Colnbrook, England), and gentamicin (Garamycin) was Amino Acid Analysis. Intracellular amino acid levels were measured in neutralized perchloric acid extracts of the cells by means of an amino acid analyzer (16) .
RESULTS AND DISCUSSION Effect of 3-Substituted Adenine Derivatives on Protein Synthesis and Degradation. Several 3-substituted adenine derivatives were tested for their effect on hepatocytic protein syn-1889
The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. thesis and degradation at concentrations of 0.1, 1, and 10 mM (Table 1) . 3-Methyladenine from two different sources showed similar activities, with very selective inhibition of protein degradation both at 1 and 10 mM. 3-Methyladenosine inhibited protein degradation to the same extent as did 3-methyladenine, but it also inhibited protein synthesis considerably at 10 mM. All of the other compounds inhibited protein synthesis as well as degradation, with the exception of 3-ribosyl-8-bromoadenine, which displayed very little activity. Thus, 3-methyladenine remains unique among the tested purines in its high selectivity towards degradation.
Inhibition of Autophagic/Lysosomal Protein Degradation by 3-Methyladenine. 3-Methyladenine inhibited endogenous protein degradation after a 20-min time lag; its effect was rapidly reversible (Fig. LA) . The purine had no significant additional effect in the presence of an amino acid mixture known to sup-
press autophagy (11) or in the presence of a lysosomotropic amine, propylamine, which inhibits lysosomal proteolysis (17) (Fig. 1B) . Therefore, it can be assumed that 3-methyladenine exerts its effect somewhere along the autophagic/lysosomal pathway of protein degradation.
The dose-response curve (Fig. 2) confirms the lack of effect of 3-methyladenine in the presence of amino acids or propylamine. 3-Methyladenine alone inhibited protein degradation by about 60% at 5 mM, with a slight additional inhibition at higher concentrations. The inhibition by 3-methyladenine never attained the level produced by propylamine or amino acids, suggesting that the autophagic/lysosomal pathway was somewhat less than completely inhibited by the purine.
3-Methyladenine Does Not Affect the Degradation of an Exogenous Protein (Asialofetuin). To see if 3-methyladenine might inhibit degradation at a step common to the autophagic (Fig. 3 ). 3-Methyladenine had no effect on asialofetuin degradation, in contrast, for instance, to propylamine, which affects lysosomes directly (17) . Therefore, the purine would seem to exert its effect upon a prelysosomal step unique to autophagy.
Depression of Intracellular Amino Acid Levels by yladenine. Because 5 mM 3-methyladenine inhibited protein degradation by about 60%, the intracellular amino acid contents would be expected to be reduced to a similar extent (16) . As shown in Table 2 , the levels of the eight amino acids measured were indeed lowered by 40-80%; the concentration of valine, the amino acid used to estimate protein degradation, was reduced by 65% as expected. This experiment would seem to rule out the possibility that the degradation-inhibitory effect of 3-methyladenine might be mediated by an elevation of intracellular amino acid levels.
Effect of 3-Methyladenine on Protein Synthesis and ATP Levels. Protein synthesis was not inhibited by 5 mM 3-methyladenine in an amino acid-supplemented medium; in fact, a slight stimulation was indicated (Fig. 4A) . Because several degradation inhibitors have been found to inhibit protein synthesis in the absence of amino acids, presumably by reducing the availability of degradation-derived amino acids needed for synthesis (18), we also tested 3-methyladenine in an amino acid-free medium. As shown in Fig. 4B , there was no inhibitory effect of the purine up to a concentration of 5 mM even under these conditions. This is surprising, considering that 5 mM 3-methyladenine greatly reduces the intracellular amino acid concentrations. One possibility is that the dose-response curve is a composite of stimulatory and inhibitory effects (compare the significant stimulation of protein synthesis by 3-methyladenine in the presence of amino acids). The fact that amino acids by Incubation time, min FIG. 3 . Effect of 3-methyladenine and propylamine on the degradation of an exogenous protein (asialofetuin). Hepatocytes which had been allowed to ingest 1 "I-labeled asialofetuin for 15 min were incubated at 370C with no additions (o), with 5 mM 3-methyladenine (e), or with 10 mM propylamine (A). Asialofetuin degradation was measured as the net release of acid-soluble 125I and was expressed as the percentage of the initial acid-insoluble radioactivity. Each value is the mean ± SEM of six cell samples from two different experiments; some of the standard errors were smaller than the symbols. themselves are stimulatory indicates that they are indeed rate limiting for protein synthesis.
Because protein synthesis is very sensitive to interference with energy metabolism (3), 3-methyladenine would not be expected to affect the latter. This could be shown more directly by measuring the intracellular ATP levels, which were unaffected by 3-methyladenine both in the presence and absence of amino acids (Fig. 4C) .
Inhibition of Autophagosome Formation by 3-Methyladenine. Formation of autophagosomes is the first step in the autophagic/lysosomal pathway and is the step that is inhibited by amino acids (10, 11) . Morphometric analysis of electron micrographs (Table 3 ) indicated a similar inhibition ofautophagosome formation by 3-methyladenine. The 80% reduction in autophagosome contents and the smaller secondary reduction in lysosome contents were somewhat less with 3-methyladenine than with amino acids, in accordance with the relative effects of the two types of treatment on overall protein degradation (cf. Fig.  2) .
Thus, our results indicate that 3-methyladenine is a specific inhibitor ofautophagy in hepatocytes. Whether other cell types are similarly affected remains to be seen. 3-Methyladenine may be useful in defining the role of autophagy under various physiological conditions, and knowledge about its mechanism of action should contribute to the understanding ofthe biochemistry ofautophagy. The ability to specifically suppress autophagy also may have practical consequences-e.g., for the maintenance and growth of cultured cells or in vivo under conditions where autophagy contributes to excessive tissue wasting. Isolated hepatocytes were incubated for 2 hr at 370C with no additions, with an amino acid mixture (11), or with 3-methyladenine (5 mM). Samples were fixed and prepared for electron microscopy, and analyzed morphometrically. Autophagosomes correspond to the vacuoles classified as type I in our previous analysis (11) , whereas secondary lysosomes comprise types II and m (i.e., including dense bodies). Each value is the mean ± SEM of five electron microscopic preparations.
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